These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35295041)

  • 1. Evaluation of iron status in anemic pre-dialysis chronic kidney disease patients.
    Waziri B; Babawale BT; Mabayoje MO
    Niger J Clin Pract; 2022 Mar; 25(3):226-230. PubMed ID: 35295041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum total iron-binding capacity and iron status in patients with non-dialysis-dependent chronic kidney disease: A cross-sectional study in Vietnam.
    Thang LV; Kien NT; Hung NV; Kien TQ; Dung NH; Huong NTT; Toan ND; Toan PQ; Vinh HT; Nghia VX; Usui T
    Asia Pac J Clin Nutr; 2020; 29(1):48-54. PubMed ID: 32229441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietic Response to Anaemia of Dialysis Naïve Patients with Chronic Kidney Disease in Zaria, North-West Nigeria.
    Dogara LG; Hassan A; Awwalu S; Okpetu L; Waziri AD; Babadoko AA; Bosan IB; Muktar HM
    Niger J Clin Pract; 2018 Feb; 21(2):189-194. PubMed ID: 29465053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
    Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
    J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
    BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.
    Vikrant S
    Saudi J Kidney Dis Transpl; 2019; 30(4):932-942. PubMed ID: 31464252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.
    Guedes M; Muenz D; Zee J; Lopes MB; Waechter S; Stengel B; Massy ZA; Speyer E; Ayav C; Finkelstein F; Sesso R; Pisoni RL; Robinson BM; Pecoits-Filho R
    Nephrol Dial Transplant; 2021 Aug; 36(9):1694-1703. PubMed ID: 33624825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency.
    Cesarano D; Borrelli S; Campilongo G; D'Ambra A; Papadia F; Garofalo C; De Marco A; Marzano F; Ruotolo C; Gesualdo L; Cirillo P; Minutolo R
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
    J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum phosphate levels and anemia in non-dialysis patients with chronic kidney disease: a retrospective cross-sectional study from the Fuji City CKD Network.
    Kato K; Nakashima A; Ohkido I; Kasai K; Yokoo T
    BMC Nephrol; 2023 Aug; 24(1):244. PubMed ID: 37605118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-marker index improves the identification of iron disorders in CKD anaemia.
    Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Gauci C; Froissart M; Stengel B;
    PLoS One; 2014; 9(2):e84144. PubMed ID: 24586229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow macrophage iron content and sideroblast count in iron- and ESA-naïve patients with CKD-related anemia.
    Capusa C; Mehedinti AM; Bârsan L; Stanciu A; Calenic A; Mircescu G
    Ren Fail; 2023 Dec; 45(1):2230300. PubMed ID: 37408484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease.
    Karava V; Dotis J; Kondou A; Christoforidis A; Taparkou A; Farmaki E; Economou M; Printza N
    Pediatr Nephrol; 2023 Aug; 38(8):2771-2779. PubMed ID: 36862253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis.
    Charytan C; Qunibi W; Bailie GR;
    Nephron Clin Pract; 2005; 100(3):c55-62. PubMed ID: 15824508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological Indices and Iron Status in Pre-Dialysis Chronic Kidney Disease Patients.
    Edeki IR; Unuigbe EI; Okaka EI
    West Afr J Med; 2024 Jan; 41(1):48-54. PubMed ID: 38412204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
    Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
    Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.